Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells

Kidney International

Volumn 72, Issue 3, 2007, Pages 319-327

  Suzuki, H ^a   Suzuki, Y ^a   Aizawa, M ^a   Yamanaka, T ^a   Kihara, M ^a   Pang, H ^a   Horikoshi, S ^a   Tomino, Y ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IgA deposition; IgA nephropathy; Immune complexes; Lymphocytes; Stem cell

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G2A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL POLARITY; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOMETRY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ANALYSIS; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEPOSITION; KIDNEY INJURY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL;

EID: 34547480308     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002300     Document Type: Article

References (48)

1. Berger J, Hinglais N. Intercapillary deposits of IgA-IgG. J Urol Nephrol 1968; 74: 694-695.
2. Grossetete B, Launay P, Lehuen A et al. Down-regulation of Fcα receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA. Kidney Int 1998; 53: 1321-1335.
3. van Zandbergen G, van Kooten C, Mohamad NK et al. Reduced binding of immunoglobulin A (IgA) from patients with primary IgA nephropathy to the myeloid IgA Fc-receptor, CD89. Nephrol Dial Transplant 1998; 13: 3058-3064.
4. Floege J. Recurrent IgA nephropathy after renal transplantation. Semin Nephrol 2004; 24: 287-291.
5. Sakai O. IgA nephropathy: current concepts and future trends. Nephrology 1997; 3: 2-3.
6. Imasawa T, Nagasawa R, Utsunomiya Y et al. Bone marrow transplantation attenuates murine IgA nephropathy: role of a stem cell disorder. Kidney Int 1999; 56: 1809-1817.
7. Coppo R, Amore A. Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 2004; 65: 1544-1547.
8. Julian BA, Novak J. IgA nephropathy: an update. Curr Opin Nephrol Hypertens 2004; 13: 171-179.
9. Allen AC, Topham PS, Harper SJ, Feehally J. Leucocyte β 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol Dial Transplant 1997; 12: 701-706.
10. Yamada K, Kobayashi N, Ikeda T et al. Alteration of IgA1 glycosylation via downregulation of core 1 β1,3-galactosyltransferase and its molecular chaperone Cosmc by Th2 cytokine. Nephrology 2006; 11: A69.
11. Chintalacharuvu SR, Emancipator SN. The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines. J Immonol 1997; 159: 2327-2333.
12. Hurtado A, Johnson RJ. Hygiene hypothesis and prevalence of glomerulonephritis. Kidney Int 2005; 97(Suppl): S62-S67.
13. Ichinose H, Miyazaki M, Koji T et al. Detection of cytokine mRNA-expressing cells in peripheral blood of patients with IgA nephropathy using non-radioactive in situ hybridization. Clin Exp Immunol 1996; 103: 125-132.
14. Ebihara I, Hirayama K, Yamamoto S et al. Th2 predominance at the single-cell level in patients with IgA nephropathy. Nephrol Dial Transplant 2001; 16: 1783-1789.
15. Yano N, Endoh M, Nomoto Y et al. Phenotypic characterization of cytokine expression in patients with IgA nephropathy. J Clin Immunol 1997; 17: 396-403.
16. Lim CS, Zheng S, Kim YS et al. Th1/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy. Nephrol Dial Transplant 2001; 16: 269-275.
17. Suzuki H, Suzuki Y, Yamanaka T et al. Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23. J Am Soc Nephrol 2005; 16: 1289-1299.
18. Gharavi AG, Yan Y, Scolari F et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 2000; 26: 354-357.
19. Nogaki F, Muso E, Kobayashi I et al. Interleukin 12 induces crescentic glomerular lesions in a high IgA strain of ddY mice, independently of changes in IgA deposition. Nephrol Dial Transplant 2000; 15: 1146-1154.
20. Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 1994; 12: 635-673.
21. Lio D, D'Anna C, Leone F et al. Hypothesis: interleukin-5 production impairment can be a key point in the pathogenesis of the MHC-linked selective IgA deficiency. Autoimmunity 1998; 27: 185-188.
22. Chintalacharuvu SR, Nagy NU, Sigmund N et al. T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation. Clin Exp Immunol 2001; 126: 326-333.
23. van den Wall Bake AW, Daha MR, Evers-Schouten J, van Es LA. Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropathy: evidence for the bone marrow as the source of mesangial IgA. Am J Kidney Dis 1988; 12: 410-414.
24. de Fijter JW, Eijgenraam JW, Braam CA et al. Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 1996; 50: 952-961.
25. Imasawa T, Utsunomiya Y, Kawamura T et al. The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol 2001; 12: 1401-1409.
26. Nguyen LT, Jacobs J, Mathis D, Benoist C. Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum 2007; 56: 509-520.
27. Martin B, Banz A, Bienvenu B et al. Suppression of CD4+ T lymphocyte effector functions by CD4+CD25+ cells in vivo. J Immunol 2004; 172: 3391-3398.
28. Mahajan D, Wang Y, Qin X et al. CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease. J Am Soc Nephrol 2006; 17: 2731-2741.
29. Arif S, Tree TI, Astill TP et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 2004; 113: 451-463.
30. Ji J, Masterson J, Sun J, Soong L. CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J Immunol 2005; 174: 7147-7153.
31. Huehn J, Hamann A. Homing to suppress: address codes for Treg migration. Trends Immunol 2005; 26: 632-636.
32. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002; 2: 151-161.
33. Rissoan MC, Soumelis V, Kadowaki N et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999; 283: 1183-1186.
34. Suzuki S, Nakatomi Y, Sato H et al. Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy. Lancet 1994; 343: 12-16.
35. Koyama A, Sharmin S, Sakurai H et al. Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int 2004; 66: 121-132.
36. Eijgenraam JW, Woltman AM, Kamerling SW et al. Dendritic cells of IgA nephropathy patients have an impaired capacity to induce IgA production in naive B cells. Kidney Int 2005; 68: 1604-1612.
37. Harper SJ, Allen AC, Layward L et al. Increased immunoglobulin A and immunoglobulin A1 cells in bone marrow trephine biopsy specimens in immunoglobulin A nephropathy. Am J Kidney Dis 1994; 24: 888-892.
38. Harper SJ, Allen AC, Pringle JH, Feehally J. Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J Clin Pathol 1996; 49: 38-42.
39. Finkelman FD, Holmes J, Katona JF et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990; 8: 303-333.
40. Holdsworth SR, Kitching AR, Tipping PG. Th1 and Th2T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int 1999; 55: 1198-1216.
41. Egido J, Sancho J, Rivera F, Hernando L. The role of IgA and IgG immune complexes in IgA nephropathy. Nephron 1984; 36: 52-59.
42. Waldo FB, Cochran AM. Mixed IgA-IgG aggregates as a model of immune complexes in IgA nephropathy. J Immunol 1989; 142: 3841-3846.
43. Czerkinsky C, Koopman WJ, Jackson S et al. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest 1986; 77: 1931-1938.
44. Tomana M, Matousovic K, Julian BA et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 1997; 52: 509-516.
45. Tomana M, Novak J, Julian BA et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 1999; 104: 73-81.
46. Novak J, Vu HL, Novak L et al. Interactions of human mesangial cells with IgA and IgA-containing immune complexes. Kidney Int 2002; 62: 465-475.
47. Katafuchi R, Kiyoshi Y, Oh Y. Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol 1998; 1: 1-8.
48. Ballardie FW, Roberts IS. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol 2002; 13: 142-148.